Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/3213
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSobirova G.N., Saidrasulova G.B., Abdullaeva U.K., Bafoeva Z.O., Ashirova N.Z., Kurbanaliev X.X., Musakhanov A.K., Gaipov O.U.-
dc.date.accessioned2026-04-06T17:44:09Z-
dc.date.available2026-04-06T17:44:09Z-
dc.date.issued2025-
dc.identifier.issn2231-2218-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/3213-
dc.description.abstractAbstract. Osteoarthritis (OA) is a multifactorial, degenerative arthritis. Factors such as obesity, low-grade chronic inflammation, and insulin resistance are key factors in the development and pathogenesis of OA. In summary, OA has been observed to associate with a number of systemic diseases, including obesity, cardiovascular disease, type 2 diabetes, and metabolic syndrome. The importance of non-alcoholic fatty liver disease based on metabolic syndrome is studied in many scientific studies. Recently, scientific work has been carried out to study metabolicassociated fatty liver disease (MAFLD) and related diseases. In this scientific work, the importance of MAFLD in the course of OA is studied.en_US
dc.language.isoenen_US
dc.publisherAsian journal of Pharmaceutical and biological researchen_US
dc.subjectosteoarthritis; metabolic syndrome; MASLD; x-ray; VAS scale;en_US
dc.titleSIGNIFICANCE OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE IN OSTEOARTHRITISen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
13. SIGNIFICANCE OF METABOLIC-ASSOCIATED FATTY LIVER.pdf393.85 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.